Home > Cashflow Statement > NATCO PHARMA

NATCO PHARMA
Cashflow Statement

NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹2,291 Cr₹1,674 Cr₹862 Cr₹202 Cr₹580 Cr
Adjustment ₹-22 Cr₹134 Cr₹102 Cr₹124 Cr₹62 Cr
Changes In working Capital ₹-200 Cr₹-309 Cr₹63 Cr₹-231 Cr₹-213 Cr
Cash Flow after changes in Working Capital ₹2,069 Cr₹1,498 Cr₹1,027 Cr₹95 Cr₹429 Cr
Cash Flow from Operating Activities ₹1,697 Cr₹1,212 Cr₹849 Cr₹47 Cr₹299 Cr
Cash Flow from Investing Activities ₹-1,415 Cr₹-1,033 Cr₹-477 Cr₹-5.30 Cr₹-103 Cr
Cash Flow from Financing Activities ₹-211 Cr₹-247 Cr₹-363 Cr₹35 Cr₹-186 Cr
Net Cash Inflow / Outflow ₹72 Cr₹-68 Cr₹9.00 Cr₹76 Cr₹9.80 Cr
Opening Cash & Cash Equivalents ₹70 Cr₹132 Cr₹111 Cr₹26 Cr₹20 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹-22 Cr₹6.50 Cr₹12 Cr₹9.30 Cr₹-3.80 Cr
Closing Cash & Cash Equivalent ₹120 Cr₹70 Cr₹132 Cr₹111 Cr₹26 Cr

Compare Cashflow Statement of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,819.0 Cr 2.3% -22% -6.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,639.0 Cr 0.9% -3.1% 7.9% Stock Analytics
DIVIS LABORATORIES ₹179,647.0 Cr 2% -2.1% -0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,366.0 Cr -2.9% -0.3% 36.4% Stock Analytics
CIPLA ₹109,528.0 Cr -2.4% -3.8% -10.1% Stock Analytics
DR REDDYS LABORATORIES ₹105,819.0 Cr -0.5% -5% -6.9% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

2.3%

-22%

-6.2%

SENSEX

4.9%

2.8%

-6.2%


You may also like the below Video Courses